Effect of apixaban for anti-atherosclerotic response in atrial fibrillation patients
Not Applicable
- Conditions
- atrial fibrillation
- Registration Number
- JPRN-UMIN000013308
- Lead Sponsor
- Yokohama Sakae Kyosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
High risk for bleeding Renal failure severe infection and trauma,perioperaion History of allergy to apixaban Ineligible in the opinion of investigators
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of inflammatory cytokine,hs-CRP,PTX3,TM Transition of blood coagulation and fibrinolysis
- Secondary Outcome Measures
Name Time Method Evaluation of atherosclerotic actions by ABI/CAVI Evaluation of atherosclerotic plaque volume by carotid artery echo